Black Diamond Therapeutics Inc - ESG Rating & Company Profile powered by AI
This Disclosure rating covers seventeen United Nations SDGs including: 'Affordable & Clean Energy', 'Decent Work & Economic Growth' and 'Life on Land'. This SDG assessment for Black Diamond Therapeutics Inc represents its reporting of the UN Sustainable Development Goals. The webpage contains a questions and answers section about Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 1.6, social score of 3.2 and governance score of 6.7.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1476 | Philogen SpA | 3.9 | Medium |
| 1476 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | 3.9 | Medium |
| 1512 | Black Diamond Therapeutics Inc | 3.8 | Medium |
| 1512 | Ampio Pharmaceuticals Inc | 3.8 | Medium |
| 1512 | Abeona Therapeutics Inc | 3.8 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Black Diamond Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Black Diamond Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Black Diamond Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Black Diamond Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Black Diamond Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Black Diamond Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Black Diamond Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Black Diamond Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penetrant inhibitor of EGFR mutations, including canonical, intrinsic resistance, and acquired resistance mutations; and BDTX-4933, a brain-penetrant inhibitor of oncogenic BRAF class I, II and III alterations. It has a strategic partnership with OpenEye Scientific Software, Inc. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.